Coronavirus vaccine results are pouring in, and it's good news for older people
Pound Slides As EU Leaders Push To Start Brexit Contingency Planning
Eli Lilly's Covid-19 partner AbCellera pays $90M for some very special mice as IPO rumors heat up
AstraZeneca COVID-19 Vaccine Shows Immune Response In Elderly
Timidity returns to the stock markets amid the accelerating pandemic
Scoop: SR One crew completes a complicated spinout from GlaxoSmithKline. And now they have a $500M fund to invest on their own
Encouraging data from AZ/Oxford coronavirus shot
"Surreal Debt Tsunami": IIF Shocked To Forecast Global Debt Hitting $360 Trillion In Ten Years
American, BA and oneworld launch transatlantic COVID-19 testing trial
What an effective vaccine might mean for a jobs recovery in the UK
Study Warns That New Work-From-Home Trend is Making People More "Racist"
Climate crisis: how museums could inspire radical action
Tapping into digital nomadism and ‘deep work’ trends, Skimlinks founder raises $1.5M for Flown
COVID-19: how many infections could returning university students cause?
Palantir has appreciated 88% in less than two months: opportunity or bubble?
COVID-19: Helping to support momentum on antimicrobial innovation
Sanofi Wins FDA Priority Review For Enzyme Therapy; Street Bullish
Currency markets drifting
Britain: Two-Stepping Toward Totalitarianism
Could a Brexit deal be possible by next week?
US retail sales sparks consolidation
UK MP Suggests People Shouldn't Be Allowed To Work Without COVID Vaccine
"Sell The Vaccine": Euphoric Wall Street Goes "Full Bull" As Optimism Hits 20 Year High, Prompting BofA To Turn Bearish
Increasing patient engagement with UK clinical trials
Will Ferrari's shares rise as fast as its first hybrid convertible?
Coronavirus treatments: keep your eye on anti-complement drugs – they look promising
Global Stocks Slide As Attention Turns To Global Economic Shutdowns
Tropical peatland conservation could protect humans from new diseases
Pfizer Kicks Off Covid-19 Vaccine Pilot Delivery Program In US - Report
Vertex Pharma’s vision for reimbursement innovation